SSRIs, SNRIs, and Pregnancy: Reassuring Data on Neurodevelopmental Outcomes
A large meta-analysis finds no causal link between prenatal antidepressant exposure and neurodevelopmental disorders after accounting for confounding factors.
Pharmacologic Treatment of Postpartum Depression: What Happens in the Real World?
New data reveal that while most women with postpartum depression start antidepressant treatment, many discontinue treatment early—highlighting persistent gaps in postpartum care.
Another Study on Antidepressants and Birth Defects: Does it Change Our Decision-Making?
Prozac (fluoxetine) was the first SSRI or selective serotonin reuptake inhibitor. Since its release in 1988, we have been gathering data on the reproductive safety of fluoxetine and other SSRIs. Over the last 32 years, [...]
Stimulants In Pregnancy and Increased Risk of Gestational Hypertension
 Our group has noted that we are seeing an increase in the number of consultations for women treated with psychostimulants in combination with an antidepressant.  The reasons vary.  Some women have depression and comorbid [...]
Antidepressants and Weight Gain: Which Ones are the Worst Offenders?
Many women are understandably concerned about the risk of weight gain associated with antidepressants. It is difficult to advise them as to which antidepressants are less or more likely to cause weight gain, as there [...]